Indeed, these studies are burdened by several limitations, most importantly the small sample size and the lack of evaluation of the therapeutic effect of GSH by liver biopsy, which to date is the gold standard for the definition of steatosis and fibrosis levels
A 2021 review in Nutrients examining the relevance of bioactive peptides in sports nutrition, including their roles in tissue repair, muscle protein synthesis, and recovery from exercise-induced damage supports the mechanistic rationale for including repair-focused peptides alongside GH secretagogues in performance-oriented protocols
For someone training for strength, this translates to tangible benefits: More Frequent Training: If you recover faster, you can hit the same muscle group again sooner, leading to a greater volume of work over time
(PubMed) That doesnt automatically translate to healthier, and it certainly doesnt translate to safe to combine with other secretagogues indefinitely. A clinician-friendly framework to evaluate any peptide stack you see online If you want the full decision logic, use Metos pillar: Heres the condensed version Id use in a consult: Step 1: Define the outcome in one sentence Not fat loss. Instead: Reduce visceral adiposity and improve triglycerides in 12 weeks, or Improve return-to-running tolerance after a tendon injury. Step 2: Grade evidence, not enthusiasm Use three buckets: A: Human outcomes evidence (best) B: Human biomarker evidence (useful but indirect) C: Preclinical/mechanistic only (hypothesis) Example: Semaglutide for weight loss: A CJC-1295 for raising IGF-1: B BPC-157/TB-500 for tendon healing: often C low B , depending on claim Step 3: Avoid redundancy If two compounds push the same pathway, youre more likely to get side effects than synergy
Gift cards from Ariya Aesthetics are the perfect gift option for any occasion
